Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NOAV) on May 25, 2021. The filing addresses a rescheduling of the company's 2021 Annual Meeting of Stockholders. Note: The request metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events and does not contain financial performance data.
Material Changes
- Annual Meeting Reschedule: The Board of Directors moved the 2021 Annual Meeting from the previously disclosed date of June 24, 2021, to August 17, 2021.
- Record Date Adjustment: The record date for stockholders eligible to vote was changed from April 29, 2021, to June 25, 2021.
- Proposal Deadline: The deadline for stockholders to submit proposals for inclusion in the proxy materials under Rule 14a-8 is now June 25, 2021.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on business outlook, or specific risk factors. The only operational detail provided is that the time and location of the rescheduled Annual Meeting will be specified in a revised proxy statement.
Investor Verification Checklist
- Verify the new Annual Meeting date of August 17, 2021, and the new record date of June 25, 2021.
- Confirm the deadline for submitting stockholder proposals (June 25, 2021) to ensure eligibility for the upcoming meeting.
- Monitor for the release of the revised proxy statement to obtain the specific time and location of the meeting.
- Confirm the registrant name is NanoVibronix, Inc., not Envue Medical, Inc., as indicated in the filing header.